Literature DB >> 19218731

Reducing the burden of coronary artery disease in India: challenges and opportunities.

Enas A Enas1, Vibhuti Singh, Y P Munjal, Suman Bhandari, Ram Dev Yadave, S C Manchanda.   

Abstract

UNLABELLED: Asian Indians--living both in India and abroad--have one of the highest rates of coronary artery disease (CAD) in the world, three times higher than the rates among Caucasians in the United States. The CAD among Indians is usually more aggressive at the time of presentation compared with whites or East Asians. The overall impact is much greater because the CAD in Asian Indians affects the "younger" working population. This kind of disproportionate epidemic among the young Indians is causing tremendous number of work days lost at a time when India is experiencing a dizzying economic boom and needs a healthy populace to sustain this boom. While the mortality and morbidity from CAD has been falling in the western world, it has been climbing to epidemic proportions among the Indian population. Various factors that are thought to contribute to this rising epidemic include urbanization of rural areas, large-scale migration of rural population to urban areas, increase in sedentary lifestyle, abdominal obesity, metabolic syndrome, diabetes, inadequate consumption of fruits and vegetables, increased use of fried, processed and fast foods, tobacco abuse, poor awareness and control of CAD risk factors, unique dyslipidemia (high triglycerides, low HDL-cholesterol levels), and possible genetic predisposition due to lipoprotein (a) [Lp(a)] excess. The effect of established, as well as novel, risk factors is multiplicative, not just additive (total effect>sum of parts). The management would require aggressive individual, societal, and governmental (policy and regulatory) interventions. Indians will require specific lower cut-offs and stricter goals for treatment of various risk factors than is currently recommended for western populations. To this end, the First Indo-US Healthcare Summit was held in New Delhi, India on December 14 and 15, 2007. The participants included representatives from several professional entities including the American Association of Physicians of Indian origin (AAPI), Indian Medical Association (IMA), Medical Council of India (MCI), and Government of India (GOI) with their main objective to address specific issues and provide precise recommendations to implement the prevention of CAD among Indians. The summary of the deliberations by the committee on "CAD among Asian Indians" and the recommendations are presented in this document.
OBJECTIVES: Discussion of demographics of CAD in Indians-both in India and abroad, current treatment strategies, primordial, primary, and secondary prevention. Development of specific recommendations for screening, evaluation and management for the prevention of CAD disease epidemic among Asian Indians. Recommendations for improving quality of care through professional, public and private initiatives.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19218731

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  22 in total

1.  The role of the total cholesterol level in the assessment of the severity of myocardial infarction.

Authors:  S Venkata Rao; Mahendra Gandhe; S Indira; P Srilakshmi; Kalyan Goswami
Journal:  J Clin Diagn Res       Date:  2013-04-02

Review 2.  Consensus statement on the management of dyslipidemia in Indian subjects: A different perspective.

Authors:  Enas A Enas; T S Dharmarajan; Basil Varkey
Journal:  Indian Heart J       Date:  2015-04-30

Review 3.  Consensus statement on management of dyslipidemia in Indian subjects.

Authors:  K Sarat Chandra; Manish Bansal; Tiny Nair; S S Iyengar; Rajeev Gupta; Subhash C Manchanda; P P Mohanan; V Dayasagar Rao; C N Manjunath; J P S Sawhney; Nakul Sinha; A K Pancholia; Sundeep Mishra; Ravi R Kasliwal; Saumitra Kumar; Unni Krishnan; Sanjay Kalra; Anoop Misra; Usha Shrivastava; Seema Gulati
Journal:  Indian Heart J       Date:  2014-12-24

4.  Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease.

Authors:  Priyanka Khandelwal; Vijaya Murugan; Smriti Hari; Ramakrishnan Lakshmy; Aditi Sinha; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2016-02-26       Impact factor: 3.714

Review 5.  Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians.

Authors:  Pramil N Singh; Kristen N Arthur; Michael J Orlich; Wesley James; Anil Purty; Jayakaran S Job; Sujatha Rajaram; Joan Sabaté
Journal:  Am J Clin Nutr       Date:  2014-05-21       Impact factor: 7.045

6.  Screening for coronary heart disease and diabetes risk in a dental setting.

Authors:  Mythili Kalladka; Barbara L Greenberg; Shreenivasa Murthy Padmashree; Nagathihally Thirumalegowda Venkateshaiah; Shilpa Yalsangi; Bangalore Nagarajachar Raghunandan; Michael Glick
Journal:  Int J Public Health       Date:  2013-12-19       Impact factor: 3.380

7.  No Racial Disparities in the Treatment of ST Elevation Myocardial Infarction - A Community-based Experience.

Authors:  Abhijeet Basoor; Gagan Randhawa; John F Cotant; Nishit Choksi; Abdul R Halabi; Kiritkumar C Patel; Michele DeGregorio
Journal:  Interv Cardiol       Date:  2013-08

8.  Pathogen burden, cytomegalovirus infection and inflammatory markers in the risk of premature coronary artery disease in individuals of Indian origin.

Authors:  Lakshmi A Mundkur; Veena S Rao; Sridhar Hebbagudi; Jayashree Shanker; Hemapriya Shivanandan; Radhika K Nagaraj; Vijay V Kakkar
Journal:  Exp Clin Cardiol       Date:  2012

Review 9.  Diabetes mellitus and its complications in India.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Nat Rev Endocrinol       Date:  2016-04-15       Impact factor: 43.330

10.  Integrative gene ontology and network analysis of coronary artery disease associated genes suggests potential role of ErbB pathway gene EGFR.

Authors:  Madankumar Ghatge; Jiny Nair; Ankit Sharma; Rajani Kanth Vangala
Journal:  Mol Med Rep       Date:  2018-01-08       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.